Skip to main content
SpringerLink
Log in

Peniskarzinom

Die Urologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 676 Accesses

Zusammenfassung

Das Peniskarzinom ist überwiegend ein aggressives Plattenepithelkarzinom mit einer relativ geringen Inzidenz in Europa und Nordamerika. Es handelt sich zwar um einen relativ langsam wachsenden Tumor, der aber im systemisch metastasierten Stadium nicht heilbar ist. Aufgrund der geringen Inzidenz ist die Studienlage unzureichend. Nicht selten wird eine Diagnose aufgrund von Patientenfaktoren erst in fortgeschrittenen Stadien gestellt. Der Mangel an Evidenz führt häufig zu individuellen Therapieversuchen mit schlechtem Ausgang. In den letzten Jahren hat das wissenschaftliche Interesse am Peniskarzinom zugenommen, durch Zentralisierung der Behandlung in einigen Ländern (Großbritannien, Niederlande) gelingt es auch zunehmend, große Behandlungsserien für die Verbesserung der Datenlage zu generieren. Dadurch konnte die Behandlung verbessert werden. Organerhalt mit plastischer Rekonstruktion und multimodale Therapiekonzepte setzen sich zunehmend durch. In Deutschland gibt es ein Peniskarzinomregister und ein Zweitmeinungszentrum, mit dem Ziel, die Behandlungsergebnisse zu verbessern.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Alnajjar HM, Lam W et al (2012) Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol 62:923

    Article  CAS  PubMed  Google Scholar 

  • Arya M, Li R, Pegler K et al (2013) Long-term trends in incidence, survival and mortality of primary penile cancer in England. Cancer Causes Control 24(12):2169–2176

    Article  PubMed  Google Scholar 

  • Backes DM, Kurman RJ, Pimenta JM et al (2009) Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 20(4):449–457

    Article  PubMed  Google Scholar 

  • Bandieramonte G, Colecchia M, Mariani L et al (2008) Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol 54(4):875–882

    Article  PubMed  Google Scholar 

  • Burt LM, Shrieve DC, Tward JD (2014) Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 88(1):94–100

    Article  PubMed  Google Scholar 

  • Chaux A, Velazquez EF, Barreto JE et al (2012) New pathologic entities in penile carcinomas: an update of the 2004 world health organization classification. Semin Diagn Pathol 29(2):59–66

    Article  PubMed  Google Scholar 

  • Chaux A, Netto GJ, Rodríguez IM et al (2013) Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol 31(4):861–867

    Article  PubMed Central  PubMed  Google Scholar 

  • Crook J, Grimard L, Pond G (2007) MP-21.03: Penile brachytherapy: results for 60 patients. Urology 70(3):161

    Article  Google Scholar 

  • Dexeus FH, Logothetis CJ et al (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146(5):1284–1287

    CAS  PubMed  Google Scholar 

  • Franks KN, Kancherla K, Sethugavalar B et al (2011) Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J Urol 186(2):524–529

    Article  PubMed  Google Scholar 

  • Graafland NM, Lam W, Leijte JA et al (2010) Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol 58(5):742–747

    Article  PubMed  Google Scholar 

  • Gunia S, Erbersdobler A, Hakenberg OW et al (2012) p16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study. J Urol 187(3):899–907

    Article  CAS  PubMed  Google Scholar 

  • Haas GP, Blumenstein BA, Gagliano RG et al (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 161(6):1823–1825

    Article  CAS  PubMed  Google Scholar 

  • Hakenberg OW, Nippgen JB et al (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98(6):1225–1227

    Article  CAS  PubMed  Google Scholar 

  • Hakenberg OW, Comperat E et al. (2014) Guideline on penile cancer. Eur Urol (im Druck)

    Google Scholar 

  • Kayes O, Minhas S, Allen C et al (2007) The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol 51(5):1313–1318, discussion 1318–1319

    Article  PubMed  Google Scholar 

  • Korets R, Koppie TM et al (2007) Partial penectomy for patients with squamous cell carcinoma of the penis: the Memorial Sloan-Kettering experience. Ann Surg Oncol 14(12):3614–3619

    Article  PubMed  Google Scholar 

  • Leijte JA, Kerst JM, Bais E et al (2007) Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52(2):488–494

    Article  CAS  PubMed  Google Scholar 

  • Leijte JA, Gallee M et al (2008a) Evaluation of current (2002) TNM classification of penile carcinoma. J Urol 180(3):933–938

    Article  PubMed  Google Scholar 

  • Leijte JA, Kirrander P et al (2008b) Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 54(1):161–168

    Article  PubMed  Google Scholar 

  • Leijte JA, Hughes B, Graafland NM et al (2009) Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol 27(20):3325–3329

    Article  PubMed  Google Scholar 

  • Lont AP, Besnard AP, Gallee MP et al (2003) A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 91(6):493–495

    Article  CAS  PubMed  Google Scholar 

  • Lont AP, Kroon BK, Horenblas S et al (2006) Presence of high risk human papilllomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 119(5):1078–1081

    Article  CAS  PubMed  Google Scholar 

  • Maden C, Sherman KJ et al (1993) History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 85(1):19–24

    Article  CAS  PubMed  Google Scholar 

  • Meijer RP, Boon TA et al (2007) Long-term follow-up after laser therapy for penile carcinoma. Urology 69(4):759–762

    Article  PubMed  Google Scholar 

  • Minhas S, Kayes O, Hegarty P et al (2005) What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int 96(7):1040–1043

    Article  PubMed  Google Scholar 

  • Morelli G, Pagni R, Mariani C et al (2009) Glansectomy with split-thickness skin graft for the treatment of penile cancer. Int J Impot Res 21(5):311–314

    Article  CAS  PubMed  Google Scholar 

  • Necchi A, Nicolai N, Colecchia M et al (2011) Proof of activity of anti-epidermal growth fator receptortargeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol 29(22):e650–e652

    Article  PubMed  Google Scholar 

  • Ornellas AA, Kinchin EW et al (2008) Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol 97(6):487–495

    Article  PubMed  Google Scholar 

  • Pagliaro LC, Williams DL et al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851–3857

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Philippou P, Shabbir M et al (2012) Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol 188(3):803–808

    Article  PubMed  Google Scholar 

  • Pizzocaro G, Piva L (1988) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6b):823–824

    Article  CAS  PubMed  Google Scholar 

  • Pizzocaro G, Nicolai N et al (2009) Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 55(3):546–551

    Article  CAS  PubMed  Google Scholar 

  • Protzel C, Alcatraz A, Horenblas S et al (2009) Lymphadenectomy in the surgical management of penile cancer. Eur Urol 55(5):1075–1088

    Article  PubMed  Google Scholar 

  • Rempelakos A, Bastas E, Lymperakis CH, Thanos A (2004) Carcinoma of the penis: experience from 360 cases. J BUON 9(1):51–55

    CAS  PubMed  Google Scholar 

  • Shabbir M, Muneer A et al (2011) Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol 59(1):142–147

    Article  PubMed  Google Scholar 

  • Smith Y, Hadway P et al (2007) Reconstructive surgery for invasive squamous carcinoma of the glans penis. Eur Urol 52(4):1179–1185

    Article  PubMed  Google Scholar 

  • Solsona E, Iborra I, Rubio J et al (2001) Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 165(5):1506–1509

    Article  CAS  PubMed  Google Scholar 

  • Tsen HF, Morgenstern H, Mack T et al (2001) Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control 12(3):267–277

    Article  CAS  PubMed  Google Scholar 

  • Windahl T, Andersson SO (2003) Combined laser treatment for penile carcinoma: results after long-term followup. J Urol 169(6):2118–2121

    Article  PubMed  Google Scholar 

  • Yao K, Tu H, Li YH et al (2010) Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome. J Urol 184(2):546–552

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Rostock, Urologische Klinik und Poliklinik, Ernst-Heydemann-Str. 6, 18055, Rostock, Deutschland

    C. Protzel

  2. Universitätsklinikum Rostock, Klinik für Urologie, Ernst-Heydemann-Str. 6, 18055, Rostock, Deutschland

    Oliver W. Hakenberg

Authors
  1. C. Protzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oliver W. Hakenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Protzel .

Editor information

Editors and Affiliations

  1. Klinik für Urologie, Universitätsmedizin Mannheim, Mannheim, Baden-Württemberg, Germany

    Maurice Stephan Michel

  2. Klinik für Urologie, Universitätsklinikum Mainz, Mainz, Germany

    Joachim W. Thüroff

  3. Klinik für Urologie, Universitätsklinikum Salzburg, Salzburg, Austria

    Günther Janetschek

  4. Klinik für Urologie, Universitätsklinikum Dresden, Dresden, Germany

    Manfred Wirth

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Protzel, C., Hakenberg, O.W. (2014). Peniskarzinom. In: Michel, M., Thüroff, J., Janetschek, G., Wirth, M. (eds) Die Urologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41168-7_20-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-41168-7_20-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-41168-7

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Peniskarzinom
    Published:
    03 September 2022

    DOI: https://doi.org/10.1007/978-3-642-41168-7_20-2

  2. Original

    Peniskarzinom
    Published:
    23 December 2014

    DOI: https://doi.org/10.1007/978-3-642-41168-7_20-1

Search

Navigation